Anúncio
Anúncio
APVO
Aptevo Therapeutics Inc
9.68
USDPatrocinado
+0.48
+5.18%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
9.10
-0.57
-5.92%
Relatórios de Lucros APVO
Rácio de surpresa positiva
APVO separação 22 de 36 últimas estimativas.
61%
Próximo Relatório
Data do Próximo Relatório
12 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.45
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-75.81%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-99.97%
Aptevo Therapeutics Inc earnings per share and revenue
On 06 de nov. de 2025, APVO reported earnings of -1.86 USD per share (EPS) for Q3 25, beating the estimate of -2.13 USD, resulting in a 12.75% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.45 USD, with revenue projected to reach -- USD, implying an diminuir of -75.81% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Aptevo Therapeutics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Aptevo Therapeutics Inc reported EPS of -$1.86, beating estimates by 12.75%, and revenue of $0.00, -- -- expectations.
How did the market react to Aptevo Therapeutics Inc's Q3 2025 earnings?
The stock price moved -- 0%, changed from $26.46 before the earnings release to $26.46 the day after.
When is Aptevo Therapeutics Inc expected to report next?
The next earning report is scheduled for 12 de fev. de 2026.
What are the forecasts for Aptevo Therapeutics Inc's next earnings report?
Based on 3
analistas, Aptevo Therapeutics Inc is expected to report EPS of -$0.45 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio